A comparison of efficacy and safety of potassium‐competitive acid blocker and proton pump inhibitor in gastric acid‐related diseases: A systematic review and meta‐analysis

BACKGROUND AND AIM: Potassium‐competitive acid blocker (PCAB) is a recent alternative to proton pump inhibitor (PPI) for potent acid suppression. The current systematic review and meta‐analysis aimed to compare the efficacy and safety of PCAB versus PPI in treating gastric acid‐related diseases. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Simadibrata, Daniel Martin, Syam, Ari Fahrial, Lee, Yeong Yeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Meta‐Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092067/
https://www.ncbi.nlm.nih.gov/pubmed/36181401
http://dx.doi.org/10.1111/jgh.16017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092067/
https://www.ncbi.nlm.nih.gov/pubmed/36181401
http://dx.doi.org/10.1111/jgh.16017

Ejemplares similares